Find Denosumab manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

27RELATED EXCIPIENT COMPANIES

45EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Denosumab

Brand Name : Xbonzy

Dosage Form : Injection Solution

Dosage Strength : 120mg

Packaging :

Approval Date : 17-11-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Denosumab

Brand Name : Acvybra

Dosage Form : Solution For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 17-11-2025

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

Dr Reddy Company Banner

03

Amgen Inc

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Amgen Inc

U.S.A
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB

Brand Name : PROLIA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 125320

Regulatory Info :

Registration Country : USA

blank

04

Amgen Inc

U.S.A
AACR Annual meeting
Not Confirmed
arrow

Amgen Inc

U.S.A
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB

Brand Name : XGEVA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 125320

Regulatory Info :

Registration Country : USA

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB-BNHT

Brand Name : BOMYNTRA

Dosage Form : INJECTION

Dosage Strength : 120MG/1.7ML (70 MG/ML)

Packaging :

Approval Date :

Application Number : 761398

Regulatory Info :

Registration Country : USA

blank

06

Samsung Bioepis

South Korea
AACR Annual meeting
Not Confirmed
arrow

Samsung Bioepis

South Korea
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB-DSSB

Brand Name : OSPOMYV

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

07

Samsung Bioepis

South Korea
AACR Annual meeting
Not Confirmed
arrow

Samsung Bioepis

South Korea
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB-DSSB

Brand Name : XBRYK

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

08

Samsung Bioepis

South Korea
AACR Annual meeting
Not Confirmed
arrow

Samsung Bioepis

South Korea
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB-DSSB

Brand Name : DENOSUMAB-DSSB

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

09

Samsung Bioepis

South Korea
AACR Annual meeting
Not Confirmed
arrow

Samsung Bioepis

South Korea
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB-DSSB

Brand Name : DENOSUMAB-DSSB

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 761392

Regulatory Info :

Registration Country : USA

blank

10

Sandoz B2B

Switzerland
AACR Annual meeting
Not Confirmed
arrow

Sandoz B2B

Switzerland
arrow
AACR Annual meeting
Not Confirmed

DENOSUMAB-BBDZ

Brand Name : JUBBONTI

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761362

Regulatory Info :

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Coating Systems & Additives

read-more
read-more

Solubilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Direct Compression

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty